MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass.

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass. Eur J Endocrinol. 2018 May 15;: Authors: Billeter AT, de la Garza Herrera J, Scheurlen KM, Nickel F, Billmann F, Müller-Stich B Abstract Obesity and its associated comorbidities have become one of the largest challenges for health care in the near future. Conservative therapy for obesity and related comorbidities have a very high failure rate and poor long-term results. Similarly, the conservative and medical management of the majority of metabolic diseases such as type 2 diabetes mellitus are only able to slow down disease progression but have no causal effect on the disease process. Obesity surgery has evolved as a highly effect therapy for severe obesity achieving long-lasting weight loss. Furthermore, several studies have demonstrated the beneficial effects of obesity surgery on reduction of overall mortality, reduction of cardiovascular events and superior control of obesity related diseases such as type 2 diabetes mellitus, dyslipidemia but also the non-alcoholic steatohepatitis compared to medical therapy. Based on these findings, the term "metabolic surgery" with the focus on treating metabolic diseases independent of body weight has been coined. Of great interest are recent studies that show that even existing complications of metabolic diseases such as diabetic nephropathy or the non-alcoholic ...
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Tags: Eur J Endocrinol Source Type: research